Open
You're reading the free version. Trader adds the live tape and alerts. Start tracking

Price with disclosed trades

Daily closes, past year · marks sit on transaction dates, sized by value

6 trades

Disclosure transactions for X4 Pharmaceuticals
Reporting person Filed Transaction Transaction value Source Actions
Craig Adam R Executive Chairman Oct 19, 2026 3-day lag Buy Oct 16, 2026 $11.88K Filed shares x price SEC Form 4 View filing
Kirske David Chief Financial Officer Oct 5, 2026 4-day lag Sale Oct 1, 2026 $33.66K Filed shares x price SEC Form 4 View filing
Volpone John President Aug 13, 2026 1-day lag Sale Aug 12, 2026 $109.23K Filed shares x price SEC Form 4 View filing
Craig Adam R Executive Chairman Aug 13, 2026 1-day lag Sale Aug 12, 2026 $210.83K Filed shares x price SEC Form 4 View filing
Gold Kelly Director Jul 1, 2026 Same-day filing Award Jul 1, 2026 $0 Filed shares x price SEC Form 4 View filing
Kirske David Chief Financial Officer Jul 1, 2026 1-day lag Sale Jun 30, 2026 $36.43K Filed shares x price SEC Form 4 View filing
Craig Adam R Executive Chairman
Buy
Calculated transaction value
$11.88K 4,600 shares @ $2.58
Traded
Oct 16, 2026
Filed
Oct 19, 2026
Kirske David Chief Financial Officer
Sale
Calculated transaction value
$33.66K 11,767 shares @ $2.86
Traded
Oct 1, 2026
Filed
Oct 5, 2026
Volpone John President
Sale
Calculated transaction value
$109.23K 24,576 shares @ $4.44
Traded
Aug 12, 2026
Filed
Aug 13, 2026
Craig Adam R Executive Chairman
Sale
Calculated transaction value
$210.83K 47,436 shares @ $4.44
Traded
Aug 12, 2026
Filed
Aug 13, 2026
Gold Kelly Director
Award
Calculated transaction value
$0 110,000 shares @ $0
Traded
Jul 1, 2026
Filed
Jul 1, 2026
Kirske David Chief Financial Officer
Sale
Calculated transaction value
$36.43K 8,543 shares @ $4.26
Traded
Jun 30, 2026
Filed
Jul 1, 2026